CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in ACAD — Acadia Pharmaceuticals Inc
CIK 884546
SAN FRANCISCO, CA
Position in ACAD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$26,123,445
-$5,189,142 QoQ
Shares Held
1,173,560
+0.1% QoQ
Ownership
0.685%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.9903711782951.ToString("F0")%
Shared 0.ToString("F0")%
None 0.009628821704897917.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. ACAD ranks #49 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in ACAD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $26,123,445 | 1,173,560 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $31,312,587 | 1,172,317 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $25,695,237 | 1,204,088 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $25,665,301 | 1,189,861 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $19,945,935 | 1,200,839 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $22,961,942 | 1,251,332 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $19,550,056 | 1,271,135 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $20,723,283 | 1,275,279 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $21,985,405 | 1,189,043 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $35,314,768 | 1,127,907 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $22,363,258 | 1,073,093 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $23,505,775 | 981,452 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $18,242,113 | 969,294 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $15,470,323 | 971,754 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $15,585,746 | 952,674 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $12,922,798 | 917,161 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $22,688,666 | 936,774 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $20,609,243 | 883,001 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $13,638,504 | 821,102 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $27,057,509 | 1,109,369 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $21,841,325 | 846,563 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $45,835,000 | 857,370 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $36,941,313 | 895,547 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $35,628,600 | 735,065 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $35,614,975 | 842,958 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||